secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2022-01-27T23:59:59+00:00
Accession:  0001193125-22-019075
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Q4 net income $1.81B ($5.75 EPS); guides 2022 rev $60-62B; $8B buyback
--------------------------------------------------------------------------

- Revenue $15.064B, net income $1.814B (diluted EPS $5.75) vs $1.426B ($4.13) in Q4 2020.
- Adjusted EBITDA $3.149B in Q4; 2022 guidance: rev $60-62B, adj EBITDA $12.55-13.05B, EPS $18.40-19.20.
- Board authorized additional $8B share repurchase program; $586M remaining under prior authorization as of Dec 31.
- Quarterly dividend declared at $0.56 per share, payable March 31, 2022.
- Andrea B. Smith appointed independent director, increasing board to 11; serves on audit and patient safety committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312522019075/0001193125-22-019075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312522019075/d292652d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-019075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer